Product in Action
Wednesday, March 26, 2025
1 PM ET
When it comes to bloodstream infections, early diagnosis and targeted treatment are crucial for improving patient outcomes. Join Dr. Dien Bard as she discusses the powerful role of VITEK® REVEAL™ in optimizing antimicrobial stewardship (AMS) practices.
This session will focus on how VITEK REVEAL's fast phenotypic antimicrobial susceptibility testing (AST) delivers reliable results in a single shift from positive blood culture, providing essential coverage for gram-negative bloodstream infections. Discover how the sepsis solution, powered by VITEK REVEAL, helps minimize delays in therapy, ensuring timely intervention and improving survival rates.
As an attendee, you will learn more about:
- How VITEK REVEAL works to accelerate AST and support sepsis management
- Best practices for integrating fast AST into your microbiology lab workflow
- The profound impact of early and targeted therapy on clinical outcomes and sepsis mortality
Don’t miss this opportunity to learn how VITEK REVEAL can revolutionize your antimicrobial stewardship efforts and improve patient care. Register now to secure your spot!
Speakers
Dr. Patrick McDaneld
Medical Advisor Lead, US Medical Affairs
bioMérieux
Jennifer Dien Bard Ph.D., D (ABMM), F (CCM)
Director of Clinical Microbiology and Virology
Children’s Hospital Los Angeles
